Cambridge, MA – Synthpop, Inc., a healthcare AI company building agentic automation to eliminate administrative bottlenecks in payer, provider, and patient operations, announced today a $15 million Series A, bringing the company’s total funding to $23 million. The round was led by Ansa Capital, with Marco DeMeireles, Co‑Founder & Managing Partner at Ansa, joining Synthpop’s Board of Directors. Defy.vc and Peterson Ventures participated in the round, alongside Storm Ventures and strategic investor Bruce Broussard.
Synthpop unifies document intelligence, payer-aware reasoning, and conversational voice agents into one coordinated system that automates up to 80% of healthcare business processes. These agents integrate directly with EHR, billing, and e-prescribe platforms, and customers use it to handle workflows that range from referrals, prior authorizations, eligibility checks, claims follow-ups, to patient access and more – reducing denials, saving costs, speeding up patient care, and lightening the overall administrative burden. Over the past year, Synthpop has demonstrated significant traction, processing over 2 million patients and now integrating with 8 major EHR systems.